Inspect historical council readings (5 recorded for this criterion)
These are separately attributed readings of this record, not independent community contributions. Versions can differ; no new consensus has been calculated.
Claude Opus 5
Not addressedRubric v2 · Historical council readingNo evidence quotation was recorded for this finding.
Recorded reference: No page reference recorded
Published rationale. The packet never says who approves the formulary or its changes. Page 10 describes Envision's flexibility through formulary management to meet the county's needs, which is a statement about vendor capability, not a grant of approval rights to the plan sponsor. There is no lowest net cost analysis requirement and no quarterly reporting of utilization management outcomes by drug, and the agreement that would carry those terms is not in the backup.
“Not addressed” is this published review’s conclusion about the produced text, not proof that a provision is absent from every version or withheld document.
Gemini 3.1 Pro
Not addressedRubric v2 · Historical council readingNo evidence quotation was recorded for this finding.
Recorded reference: No page reference recorded
Published rationale. The memo mentions the PBM's flexibility through formulary management but lacks the executed agreement to confirm if the plan sponsor has final approval control over the formulary.
“Not addressed” is this published review’s conclusion about the produced text, not proof that a provision is absent from every version or withheld document.
GPT 5.6 Sol
Weaker than the modelRubric v2 · Historical council readingEnvision also has the flexibility through formulary management and pharmacy network management to meet the County’s current and future needs.
Recorded reference: Page 10
Open source PDF near page 10 ↗Page navigation follows the recorded reference; check printed numbering against the PDF.
Published rationale. Formulary management is part of the proposed service and is described as responsive to County needs. The language gives Envision flexibility rather than reserving approval of the formulary and every change to Travis County. No lowest-net-cost analysis or quarterly drug-level utilization management reporting duty is shown in the absent agreement.
Grok 4.6
Not addressedRubric v2 · Historical council readingNo evidence quotation was recorded for this finding.
Recorded reference: No page reference recorded
Published rationale. Pages 2 and 10 praise Envision flexibility through formulary management to meet County needs. That is PBM-side flexibility, not a rule that Travis County approves the formulary and every change or receives lowest-net-cost analysis and quarterly utilization management outcomes. No formulary control clause appears in the backup.
“Not addressed” is this published review’s conclusion about the produced text, not proof that a provision is absent from every version or withheld document.
Kimi K3
Not addressedRubric v2 · Historical council readingNo evidence quotation was recorded for this finding.
Recorded reference: No page reference recorded
Published rationale. Page 10 says Envision has flexibility through formulary management to meet the County's needs, and page 9 lists a covered PDL as an evaluation criterion, but nothing states that the County approves the formulary or its changes or receives utilization management outcomes. Formulary control terms would be in the executed agreement and the formulary exhibit, neither of which is in the file.
“Not addressed” is this published review’s conclusion about the produced text, not proof that a provision is absent from every version or withheld document.